Clinical Trial Update: An Ultra-short Course of Primaquine for the Radical Cure of Vivax Malaria [Phase 3]

View source ↗

Summary

Phase 3 study evaluating an ultra-short course of primaquine for radical cure of Plasmodium vivax malaria; recruitment is not yet started.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plasmodium Vivax Malaria

Drugs mentioned

• Primaquine (primaquine)

Snippet

Sponsor: Menzies School of Health Research | Conditions: Malaria | Phase 3 | Status: NOT_YET_RECRUITING